Abstract
Respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis, represent a significant burden on global health. Pharmaceutical strategies have played a critical role in the management and treatment of these diseases. This article provides an in-depth review of current pharmaceutical treatments, including bronchodilators, corticosteroids, biologic therapies, and newer investigational drugs. We also discuss challenges in drug delivery and the future of personalized medicine in the management of respiratory diseases.
References
Ahmad, N. R. (2025). Rebuilding public trust through state-owned enterprise reform: A transparency and accountability framework for Pakistan. Punjab Sahulat Bazaars Authority. https://doi.org/10.52152/6q2p9250
Ahmad, N. R. (2025). Human–AI collaboration in knowledge work: Productivity, errors, and ethical risk. https://doi.org/10.52152/6q2p9250

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Dr. Ahmed Khan (Author)